Sign In

Jim Connolly

Board Director and Advisor

Jim Connolly is a member of the Board of Directors at Valneva, a specialty vaccine company.12 He is an experienced executive with over three decades of experience in the life sciences industry.1 Connolly was appointed to Valneva's Supervisory Board in June 2022 for a three-year term.1

Prior to his role at Valneva, Connolly had a successful 24-year career at Wyeth (now Pfizer), where he held senior positions including Executive Vice President and General Manager of Wyeth Vaccines and President of Wyeth Canada.1 From 2010 to 2013, he served as President and CEO of Aeras (now IAVI).1

Since 2013, Connolly has been serving on boards for various vaccine, biopharmaceutical, and investment organizations.1 His LinkedIn profile indicates that he is currently seeking advisory, Board, or consulting roles with early, development, or commercial stage companies.3

Connolly's extensive experience in the vaccine industry, particularly his role in building Wyeth's vaccines business into one of the top four global manufacturers and his involvement in creating the blockbuster vaccine Prevnar, makes him a valuable asset to Valneva's board.1

Highlights

Nov 5 · valneva.com
Our Team - Valneva
Our Team - Valneva
Jun 24 · valneva.com
Valneva Announces Successful Outcome of its AGM and ...

Related Questions

What are Jim Connolly's main responsibilities at Valneva?
How did Jim Connolly contribute to the success of Wyeth Vaccines?
What is Jim Connolly's background before joining Valneva?
How has Jim Connolly's experience at Aeras influenced his career?
What are some of the notable achievements of Jim Connolly in the life sciences industry?
Jim Connolly
Jim Connolly, photo 1
Jim Connolly, photo 2
Add to my network

Location

Wayne, Pennsylvania, United States